Telomir seeks FDA approval for Telomir-1 to treat breast cancer
Telomir Pharmaceuticals has submitted an IND application to the FDA for Telomir-1, its lead candidate targeting advanced and metastatic TNBC.
Read the full article on the original site.
Read Full Article